$Co-diagnostics (CODX.US)$After listing in 2017, it had reve...
$Co-diagnostics(CODX.US$After listing in 2017, it had revenue of $75 million until 2020, which grew to $98 million in 2021, but fell sharply by 65% to $34 million in 2022. Operating profit was 42 million and 046 million dollars in 2020 and 2021, respectively, and there was a slight loss for the remaining 3 years. Net profit is similar to operating profit.
Revenue for 2023Q1 fell 97.4%, and operating profit and net profit continued to lose as expected.
Currently, revenue fluctuates greatly, and profit predictability is very poor, but the balance sheet is very stable.
Cash has reached 75.3 million, total debt is only 6.37 million, and total debt minus cash is 68.9 million. Currently, the market value is only 33.3 million. However, this discount is still too small compared to losses. If you continue to lose money for 1 year, you can finish losing money. Currently, it's not attractive.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
